NEWS & MEDIA
Monoclonal antibody therapy is a promising form of treatment for COVID‑19.
The U.S. Food and Drug Administration (FDA) authorized booster doses of the COVID-19 vaccines made by Moderna and Johnson & Johnson following unanimous votes by a committee of independent advisers backing the boosters last week.
Ivermectin, the controversial drug popular among anti-vaccine advocates, will be tested as a treatment for COVID-19 symptoms in a new clinical trial.
The U.S. Food and Drug Administration (FDA) said on Thursday it has revised its Emergency Use Authorization (EUA) for Eli Lilly's (LLY.N) COVID-19 antibody cocktail to include for use in patients who have been exposed to the virus and are at high risk for progression to severe disease.